Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Classement en actions #26682
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Prix de l'action
$3.49
Dernière synchronisation: 2023-12-19
Capitalisation boursière
$38.68M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Neoleukin Therapeutics, Inc. (NLTX)

Catégorie

Historique du prix de l'action pour Neoleukin Therapeutics, Inc. (NLTX)
Prix de clôture le plus élevé : $3.45 le 2023-12-01

Prix de clôture le plus bas : $64.26 le 2014-03-01
Historique du prix de l'action de Neoleukin Therapeutics, Inc. de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$163.81 25.91%
DE
$38.00 22.72%
JP
$219.60 32.64%
CH
$21.01 11.96%
IN